InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
WFB | Ann: FULL-YEAR RESULTS 2018 WFD UNIBAIL-RODAMCO N.V. | 20/03/19 | 0 | 75 | |||
|
|||||||
WFB | Ann: URW: FULL-YEAR RESULTS 2018 WFD UNIBAIL-RODAMCO N.V. | 20/03/19 | 0 | 66 | |||
|
|||||||
WFB | Ann: URW FY 2018 Results | 14/02/19 | 0 | 78 | |||
|
|||||||
WFB | Ann: URW Financial information as at September 30, 2018 | 26/10/18 | 0 | 118 | |||
|
|||||||
WFB | Ann: Articles of Association of UR SE | 26/10/18 | 0 | 106 | |||
|
|||||||
WFB | Ann: HALF-YEAR RESULTS 2018 WFD UNIBAIL-RODAMCO N.V. | 01/10/18 | 0 | 63 | |||
|
|||||||
WFB | Ann: URW announces successful placement of U.S.$1.0 Bn of bonds | 01/10/18 | 0 | 138 | |||
|
|||||||
WFB | Ann: 20180829 URW Half Year 2018 Results | 31/08/18 | 0 | 114 | |||
|
See All Discussions